These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15849373)

  • 21. Amino Acids in Circulatory Function and Health.
    Durante W
    Adv Exp Med Biol; 2020; 1265():39-56. PubMed ID: 32761569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arginine attenuates methylglyoxal- and high glucose-induced endothelial dysfunction and oxidative stress by an endothelial nitric-oxide synthase-independent mechanism.
    Dhar I; Dhar A; Wu L; Desai K
    J Pharmacol Exp Ther; 2012 Jul; 342(1):196-204. PubMed ID: 22518022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. L-arginine and arginine analogues: effects on isolated blood vessels and cultured endothelial cells.
    Schmidt HH; Baeblich SE; Zernikow BC; Klein MM; Böhme E
    Br J Pharmacol; 1990 Sep; 101(1):145-51. PubMed ID: 2282457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An arginine analog inhibits responses of both the endothelium and smooth muscle of canine in situ vein grafts.
    Rhee RY; Gloviczki P; Miller VM
    Cardiovasc Surg; 1997 Apr; 5(2):169-75. PubMed ID: 9212203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arginine and nitric oxide synthase: regulatory mechanisms and cardiovascular aspects.
    Lorin J; Zeller M; Guilland JC; Cottin Y; Vergely C; Rochette L
    Mol Nutr Food Res; 2014 Jan; 58(1):101-16. PubMed ID: 23740826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of guanidino compounds on the endothelium-derived relaxing factor inhibitor NG-monomethyl L-arginine.
    Thomas G; Ramwell PW
    J Pharmacol Exp Ther; 1991 Nov; 259(2):490-4. PubMed ID: 1719191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The L-arginine-nitric oxide pathway in the canine femoral vascular bed: in vitro and in vivo experiments.
    Richard V; Gosgnach M; Drieu la Rochelle C; Giudicelli JF; Berdeaux A
    Fundam Clin Pharmacol; 1991; 5(9):777-88. PubMed ID: 1794833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormalities in L-arginine transport and nitric oxide biosynthesis in chronic renal and heart failure.
    Mendes Ribeiro AC; Brunini TM; Ellory JC; Mann GE
    Cardiovasc Res; 2001 Mar; 49(4):697-712. PubMed ID: 11230969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered L-arginine metabolism results in increased nitric oxide release from uraemic endothelial cells.
    Thuraisingham RC; Roberts NB; Wilkes M; New DI; Mendes-Ribeiro AC; Dodd SM; Yaqoob MM
    Clin Sci (Lond); 2002 Jul; 103(1):31-41. PubMed ID: 12095401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM) in vitro: antinociceptive and cardiovascular effects.
    Handy RL; Harb HL; Wallace P; Gaffen Z; Whitehead KJ; Moore PK
    Br J Pharmacol; 1996 Sep; 119(2):423-31. PubMed ID: 8886430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amelioration by L-arginine of a dysfunctional arginine/nitric oxide pathway in diabetic endothelium.
    Pieper GM; Peltier BA
    J Cardiovasc Pharmacol; 1995 Mar; 25(3):397-403. PubMed ID: 7769804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antihypertensive therapy augments endothelium-dependent relaxations in coronary arteries of spontaneously hypertensive rats.
    Tschudi MR; Criscione L; Novosel D; Pfeiffer K; Lüscher TF
    Circulation; 1994 May; 89(5):2212-8. PubMed ID: 8181147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelium-dependent relaxation of small arteries from essential hypertensive patients: mechanisms and comparison with normotensive subjects and with responses of vessels from spontaneously hypertensive rats.
    Deng LY; Li JS; Schiffrin EL
    Clin Sci (Lond); 1995 Jun; 88(6):611-22. PubMed ID: 7543395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of disease: L-arginine in coronary atherosclerosis--a clinical perspective.
    Tousoulis D; Böger RH; Antoniades C; Siasos G; Stefanadi E; Stefanadis C
    Nat Clin Pract Cardiovasc Med; 2007 May; 4(5):274-83. PubMed ID: 17457351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimizing nitric oxide production by time dependent L-arginine administration in isolated human corpus cavernosum.
    Gur S; Kadowitz PJ; Trost L; Hellstrom WJ
    J Urol; 2007 Oct; 178(4 Pt 1):1543-8. PubMed ID: 17707054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nebivolol: endothelium-mediated vasodilating effect.
    Ritter JM
    J Cardiovasc Pharmacol; 2001 Dec; 38 Suppl 3():S13-6. PubMed ID: 11811387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: cultured endothelial cells recycle L-citrulline to L-arginine.
    Hecker M; Sessa WC; Harris HJ; Anggård EE; Vane JR
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8612-6. PubMed ID: 2236071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. R59949, a diacylglycerol kinase inhibitor, inhibits inducible nitric oxide production through decreasing transplasmalemmal L-arginine uptake in vascular smooth muscle cells.
    Shimomura T; Nakano T; Goto K; Wakabayashi I
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Feb; 390(2):207-214. PubMed ID: 27909743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual effects of insulin-like growth factor-I on the constitutive and inducible nitric oxide (NO) synthase-dependent formation of NO in vascular cells.
    Schini-Kerth VB
    J Endocrinol Invest; 1999; 22(5 Suppl):82-8. PubMed ID: 10442576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Influence of L-arginine on development of atherosclerosis: what is the therapeutically assured?].
    Bode-Böger SM
    Dtsch Med Wochenschr; 2005 Mar; 130(11):593-8. PubMed ID: 15761791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.